BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bandello F, Lattanzio R, Zucchiatti I, Del Turco C. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 2013;50:1-20. [PMID: 23277338 DOI: 10.1007/s00592-012-0449-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Dong C, Liu P, Wang H, Dong M, Li G, Li Y. Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats1. Acta Cir Bras 2019;34:e201900201. [PMID: 30843934 DOI: 10.1590/s0102-8650201900201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Choi JA, Chung YR, Byun HR, Park H, Koh JY, Yoon YH. The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. Toxicol Appl Pharmacol 2017;315:80-9. [PMID: 27939241 DOI: 10.1016/j.taap.2016.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
3 Chung YR, Ha KH, Lee K, Kim DJ. Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study. PLoS One 2019;14:e0224549. [PMID: 31658289 DOI: 10.1371/journal.pone.0224549] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Chung YR, Ha KH, Kim HC, Park SJ, Lee K, Kim DJ. Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study. Diabetes Metab J 2019;43:640-8. [PMID: 30877707 DOI: 10.4093/dmj.2018.0137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang ZZ, Qin XH, Zhang J. MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating BTG1-mediated PI3K/Akt/VEGF signaling pathway. Am J Physiol Endocrinol Metab 2019;316:E1050-60. [PMID: 30835506 DOI: 10.1152/ajpendo.00444.2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
6 Plotas P, Makri OE, Georgalas I, Pharmakakis N, Vantarakis A, Georgakopoulos CD. Efficacy of Topical Ofloxacin 0.3 % Administration on Conjunctival Bacterial Flora in Diabetic Patients Undergoing Intravitreal Injections. Semin Ophthalmol 2017;32:738-42. [PMID: 27487463 DOI: 10.3109/08820538.2016.1170165] [Reference Citation Analysis]
7 Liegl R, Langer J, Seidensticker F, Reznicek L, Haritoglou C, Ulbig MW, Neubauer AS, Kampik A, Kernt M. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One. 2014;9:e113981. [PMID: 25541960 DOI: 10.1371/journal.pone.0113981] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
8 Liu Z, Jiang H, Townsend JH, Wang J. Effects of Ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene. BMJ Open Diabetes Res Care 2021;9:e002327. [PMID: 34521653 DOI: 10.1136/bmjdrc-2021-002327] [Reference Citation Analysis]
9 Broadhead GK, Hong T, Bahrami B, Flood V, Liew G, Chang AA. Diet and risk of visual impairment: a review of dietary factors and risk of common causes of visual impairment. Nutr Rev 2021;79:636-50. [PMID: 33051676 DOI: 10.1093/nutrit/nuaa100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Nebbioso M, Lambiase A, Armentano M, Tucciarone G, Bonfiglio V, Plateroti R, Alisi L. The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies. Antioxidants (Basel) 2020;9:E666. [PMID: 32722545 DOI: 10.3390/antiox9080666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Zhou KK, Benyajati S, Le Y, Cheng R, Zhang W, Ma JX. Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization. PLoS One 2014;9:e108454. [PMID: 25271989 DOI: 10.1371/journal.pone.0108454] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
12 Gong Q, Wang H, Yu P, Qian T, Xu X. Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy. Front Med (Lausanne) 2021;8:644121. [PMID: 33842506 DOI: 10.3389/fmed.2021.644121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang L, Wang N, Tan HY, Zhang Y, Feng Y. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy. J Ethnopharmacol 2015;169:295-304. [PMID: 25929449 DOI: 10.1016/j.jep.2015.04.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
14 Graff EC, Fang H, Wanders D, Judd RL. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism 2016;65:102-13. [PMID: 26773933 DOI: 10.1016/j.metabol.2015.10.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 9.4] [Reference Citation Analysis]
15 Gao J, Pan L, Bi R, Shi Y, Han Y, Tang X, Lai X. Tibetan Medicines and Tibetan Prescriptions for the Treatment of Diabetes Mellitus. Evid Based Complement Alternat Med 2021;2021:5532159. [PMID: 34055007 DOI: 10.1155/2021/5532159] [Reference Citation Analysis]
16 Anjana RM, Shanthirani CS, Unnikrishnan R, Mugilan P, Amutha A, Nair HD, Subhashini S, Venkatesan U, Ali MK, Ranjani H, Mohan V. Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetol 2015;52:601-9. [PMID: 25539883 DOI: 10.1007/s00592-014-0701-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
17 Lorusso M, Milano V, Nikolopoulou E, Ferrari LM, Cicinelli MV, Querques G, Ferrari TM. Panretinal Photocoagulation Does Not Change Macular Perfusion in Eyes With Proliferative Diabetic Retinopathy. Ophthalmic Surg Lasers Imaging Retina 2019;50:174-8. [DOI: 10.3928/23258160-20190301-07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
18 Wang Y, Tao J, Jiang M, Yao Y. Apocynin ameliorates diabetic retinopathy in rats: Involvement of TLR4/NF-κB signaling pathway. Int Immunopharmacol 2019;73:49-56. [PMID: 31078925 DOI: 10.1016/j.intimp.2019.04.062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
19 Ometto G, Erlandsen M, Hunter A, Bek T. The role of retinopathy distribution and other lesion types for the definition of examination intervals during screening for diabetic retinopathy. Acta Ophthalmol 2017;95:400-4. [PMID: 27864877 DOI: 10.1111/aos.13334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 He R, Shen J, Zhao J, Zeng H, Li L, Zhao J, Liu F, Jia W. High cystatin C levels predict severe retinopathy in type 2 diabetes patients. Eur J Epidemiol 2013;28:775-8. [DOI: 10.1007/s10654-013-9839-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
21 Pietrucha-Dutczak M, Amadio M, Govoni S, Lewin-Kowalik J, Smedowski A. The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration. Front Neurosci 2018;12:834. [PMID: 30524222 DOI: 10.3389/fnins.2018.00834] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
22 Shafabakhsh R, Aghadavod E, Mobini M, Heidari-Soureshjani R, Asemi Z. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy. J Cell Physiol 2019;234:7781-7. [PMID: 30478931 DOI: 10.1002/jcp.27685] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
23 Bek T. Mitochondrial dysfunction and diabetic retinopathy. Mitochondrion 2017;36:4-6. [PMID: 27456429 DOI: 10.1016/j.mito.2016.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
24 Du A, Xie Y, Ouyang H, Lu B, Jia W, Xu H, Ji L. Si-Miao-Yong-An Decoction for Diabetic Retinopathy: A Combined Network Pharmacological and In Vivo Approach. Front Pharmacol 2021;12:763163. [PMID: 34899317 DOI: 10.3389/fphar.2021.763163] [Reference Citation Analysis]
25 Usuelli V, La Rocca E. Novel therapeutic approaches for diabetic nephropathy and retinopathy. Pharmacol Res. 2015;98:39-44. [PMID: 25447794 DOI: 10.1016/j.phrs.2014.10.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
26 Jensen TM, Vistisen D, Fleming T, Nawroth PP, Jørgensen ME, Lauritzen T, Sandbæk A, Witte DR. Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study. Acta Diabetol 2015;52:929-36. [DOI: 10.1007/s00592-015-0739-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rilvén S, Torp TL, Grauslund J. Retinal oximetry in patients with ischaemic retinal diseases. Acta Ophthalmol 2017;95:119-27. [DOI: 10.1111/aos.13229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
28 Qian X, Lin L, Zong Y, Yuan Y, Dong Y, Fu Y, Shao W, Li Y, Gao Q. Shifts in renin-angiotensin system components, angiogenesis, and oxidative stress-related protein expression in the lamina cribrosa region of streptozotocin-induced diabetic mice. Graefes Arch Clin Exp Ophthalmol 2018;256:525-34. [PMID: 29404759 DOI: 10.1007/s00417-017-3866-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Petersen L, Bek T. The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis. Graefes Arch Clin Exp Ophthalmol 2016;254:2339-46. [PMID: 27270566 DOI: 10.1007/s00417-016-3399-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
30 Rezzola S, Loda A, Corsini M, Semeraro F, Annese T, Presta M, Ribatti D. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform. Front Immunol 2020;11:581288. [PMID: 33117388 DOI: 10.3389/fimmu.2020.581288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen W, Yao X, Zhou C, Zhang Z, Gui G, Lin B. Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation. Mediators Inflamm 2017;2017:3059763. [PMID: 28638179 DOI: 10.1155/2017/3059763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Liu WL. MicroRNA-9 inhibits retinal neovascularization in rats with diabetic retinopathy by targeting vascular endothelial growth factor A. J Cell Biochem 2018. [PMID: 30485520 DOI: 10.1002/jcb.28081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
33 Mazzeo A, Beltramo E, Iavello A, Carpanetto A, Porta M. Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy. Acta Diabetol 2015;52:1113-9. [DOI: 10.1007/s00592-015-0798-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
34 Seo EJ, Choi JA, Koh JY, Yoon YH. Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice. BMJ Open Diabetes Res Care 2020;8:e001278. [PMID: 33077473 DOI: 10.1136/bmjdrc-2020-001278] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Skov Jensen P, Metz Mariendal Pedersen S, Aalkjaer C, Bek T. The vasodilating effects of insulin and lactate are increased in precapillary arterioles in the porcine retina ex vivo. Acta Ophthalmol 2016;94:454-62. [PMID: 27009434 DOI: 10.1111/aos.13025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
36 Cho EH, Park SJ, Han S, Song JH, Lee K, Chung YR. Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy. J Diabetes Res 2018;2018:6807219. [PMID: 30622970 DOI: 10.1155/2018/6807219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Walpole J, Mac Gabhann F, Peirce SM, Chappell JC. Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage. Microcirculation 2017;24. [PMID: 28791758 DOI: 10.1111/micc.12393] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
38 Nawaz IM, Chiodelli P, Rezzola S, Paganini G, Corsini M, Lodola A, Di Ianni A, Mor M, Presta M. N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors. Angiogenesis 2018;21:47-59. [PMID: 29030736 DOI: 10.1007/s10456-017-9581-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
39 Pyun BJ, Kim YS, Lee IS, Kim JS. Homonoia riparia and its major component, myricitrin, inhibit high glucose-induced apoptosis of human retinal pericytes. Integr Med Res 2017;6:300-9. [PMID: 28951844 DOI: 10.1016/j.imr.2017.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
40 Fang S, Ma X, Guo S, Lu J. MicroRNA-126 inhibits cell viability and invasion in a diabetic retinopathy model via targeting IRS-1. Oncol Lett 2017;14:4311-8. [PMID: 28943945 DOI: 10.3892/ol.2017.6695] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
41 Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic Retinopathy. Prim Care 2015;42:451-64. [PMID: 26319349 DOI: 10.1016/j.pop.2015.05.005] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 16.5] [Reference Citation Analysis]
42 Shin ES, Sorenson CM, Sheibani N. Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res 2014;9:362-73. [PMID: 25667739 DOI: 10.4103/2008-322X.143378] [Cited by in F6Publishing: 63] [Reference Citation Analysis]
43 Chhetri J, Jacobson G, Gueven N. Zebrafish--on the move towards ophthalmological research. Eye (Lond) 2014;28:367-80. [PMID: 24503724 DOI: 10.1038/eye.2014.19] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 9.3] [Reference Citation Analysis]
44 Feng Y, Wang Y, Yang Z, Wu L, Hoffmann S, Wieland T, Gretz N, Hammes HP. Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration. Acta Diabetol 2014;51:211-8. [PMID: 23771613 DOI: 10.1007/s00592-013-0488-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
45 Chung YR, Choi JA, Koh JY, Yoon YH. Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice. J Diabetes Res 2017;2017:1763292. [PMID: 28127564 DOI: 10.1155/2017/1763292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
46 Francis AW, Wanek J, Shahidi M. Assessment of Global and Local Alterations in Retinal Layer Thickness in Ins2 (Akita) Diabetic Mice by Spectral Domain Optical Coherence Tomography. J Ophthalmol 2018;2018:7253498. [PMID: 29675273 DOI: 10.1155/2018/7253498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Nicolucci A, Buseghin G, De Portu S. Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting. Acta Diabetol 2016;53:199-204. [PMID: 25943859 DOI: 10.1007/s00592-015-0755-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Mohan A, Saxena S, De S, Kaur A, Ali W, Gilhotra JS, Meyer CH. Increased serum cortisol is associated with alterations in cross-sectional and topographic OCT parameters in diabetic retinopathy: a preliminary study. Int Ophthalmol 2021. [PMID: 34189705 DOI: 10.1007/s10792-021-01941-8] [Reference Citation Analysis]
49 Pirie FJ, Maharaj S, Esterhuizen TM, Paruk IM, Motala AA. Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors. J Clin Transl Endocrinol 2014;1:e9-e12. [PMID: 29235587 DOI: 10.1016/j.jcte.2013.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Jian W, Yu S, Tang M, Duan H, Huang J. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats. Journal of Ethnopharmacology 2016;182:50-6. [DOI: 10.1016/j.jep.2015.11.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
51 Perticone M, Tassone EJ, Scarpino PE, Naccarato P, Addesi D, di Cello S, Sciacqua A, Maio R, Andreucci M, Carrao S, Licata A, Sesti G, Perticone F. Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients. Acta Diabetol 2016;53:41-7. [DOI: 10.1007/s00592-015-0740-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
52 Azzolini C, Sansoni G, Donati S, Parodi MB, Oum MA, Vinciguerra R, Tartaglia V, Semeraro F, Virgili G. Clinical Analysis of Macular Edema with New Software for SD-OCT Imaging. European Journal of Ophthalmology 2018;23:899-904. [DOI: 10.5301/ejo.5000329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rinaldi M, dell'Omo R, Morescalchi F, Semeraro F, Gambicorti E, Cacciatore F, Chiosi F, Costagliola C. ILM peeling in nontractional diabetic macular edema: review and metanalysis. Int Ophthalmol 2018;38:2709-14. [PMID: 29090356 DOI: 10.1007/s10792-017-0761-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
54 Gong Q, Dong W, Fan Y, Chen F, Bian X, Xu X, Qian T, Yu P. LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy. Front Pharmacol 2019;10:1703. [PMID: 32082175 DOI: 10.3389/fphar.2019.01703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ. Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression. PLoS One 2016;11:e0161897. [PMID: 27564383 DOI: 10.1371/journal.pone.0161897] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
56 Yang X, Xu J, Liu J, Ni N, Mei Y, Lei H, Wang J, Niu B. Acetagastrodin effects on retinal oscillatory potentials in patients during the early stages of diabetes. Acta Diabetol 2017;54:73-9. [DOI: 10.1007/s00592-016-0914-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Sun S, Li M, Zhou J, Gai Z, Shi H, Zhao Q, Tian J. Cystatin C predicts diabetic retinopathy in Chinese patients with type 2 diabetes. Int J Diabetes Dev Ctries 2015;35:398-404. [DOI: 10.1007/s13410-015-0383-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Chen J, Wan Y, Su J, Zhu Z, Pan E, Shen C, Wen J, Wang K, Yu H, Qin Y, Cui L, Zhou J, Wu M. Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic Patients. Acta Diabetol 2021. [PMID: 34713323 DOI: 10.1007/s00592-021-01806-7] [Reference Citation Analysis]
59 Chung YR, Park SW, Kim JW, Kim JH, Lee K. PROTECTIVE EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES. Retina 2016;36:2357-63. [PMID: 27285457 DOI: 10.1097/IAE.0000000000001098] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
60 Jin CJ, Yu SH, Wang XM, Woo SJ, Park HJ, Lee HC, Choi SH, Kim KM, Kim JH, Park KS, Jang HC, Lim S. The effect of lithospermic acid, an antioxidant, on development of diabetic retinopathy in spontaneously obese diabetic rats. PLoS One 2014;9:e98232. [PMID: 24905410 DOI: 10.1371/journal.pone.0098232] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
61 Ola MS. Effect of hyperglycemia on insulin receptor signaling in the cultured retinal Müller glial cells. Biochemical and Biophysical Research Communications 2014;444:264-9. [DOI: 10.1016/j.bbrc.2014.01.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
62 Ji Z, Luo J, Su T, Chen C, Su Y. miR-7a Targets Insulin Receptor Substrate-2 Gene and Suppresses Viability and Invasion of Cells in Diabetic Retinopathy Mice via PI3K-Akt-VEGF Pathway. Diabetes Metab Syndr Obes 2021;14:719-28. [PMID: 33623407 DOI: 10.2147/DMSO.S288482] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Cammalleri M, Dal Monte M, Locri F, Marsili S, Lista L, De Rosa M, Pavone V, Rusciano D, Bagnoli P. Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System. J Diabetes Res 2017;2017:2904150. [PMID: 29464181 DOI: 10.1155/2017/2904150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
64 Hu K, Tang X, Tang G, Yao S, Yao B, Wang H, Nie D, Liang X, Tang C, He S. 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. PLoS One 2015;10:e0138675. [PMID: 26397833 DOI: 10.1371/journal.pone.0138675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
65 Mazzeo A, Lopatina T, Gai C, Trento M, Porta M, Beltramo E. Functional analysis of miR-21-3p, miR-30b-5p and miR-150-5p shuttled by extracellular vesicles from diabetic subjects reveals their association with diabetic retinopathy. Experimental Eye Research 2019;184:56-63. [DOI: 10.1016/j.exer.2019.04.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
66 Krishnaswami V, Kandasamy R, Alagarsamy S, Palanisamy R, Natesan S. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. International Journal of Biological Macromolecules 2018;110:7-16. [DOI: 10.1016/j.ijbiomac.2018.01.120] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
67 Madrakhimov SB, Yang JY, Kim JH, Han JW, Park TK. mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy. Cell Commun Signal 2021;19:29. [PMID: 33637094 DOI: 10.1186/s12964-020-00698-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
68 Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz IM, Coltrini D, Mitola S, Ronca R, Belleri M, Lista L, Rusciano D, De Rosa M, Pavone V, Semeraro F, Presta M. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy. Diabetologia 2017;60:719-28. [PMID: 28083635 DOI: 10.1007/s00125-016-4204-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
69 Rodríguez ML, Pérez S, Mena-Mollá S, Desco MC, Ortega ÁL. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.Oxid Med Cell Longev. 2019;2019:4940825. [PMID: 31814880 DOI: 10.1155/2019/4940825] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
70 Whitehead M, Wickremasinghe S, Osborne A, Van Wijngaarden P, Martin KR. Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies. Expert Opin Biol Ther. 2018;18:1257-1270. [PMID: 30408422 DOI: 10.1080/14712598.2018.1545836] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
71 Hussein KA, Choksi K, Akeel S, Ahmad S, Megyerdi S, El-Sherbiny M, Nawaz M, Abu El-Asrar A, Al-Shabrawey M. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Exp Eye Res 2014;125:79-88. [PMID: 24910902 DOI: 10.1016/j.exer.2014.05.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
72 Haritoglou C, Kernt M, Wolf A. [Diabetic maculopathy]. Ophthalmologe 2015;112:871-83; quiz 884-6. [PMID: 26420681 DOI: 10.1007/s00347-015-0127-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
73 Mugisho OO, Green CR, Zhang J, Acosta ML, Rupenthal ID. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy. Drug Discov Today 2019;24:1627-36. [PMID: 30690195 DOI: 10.1016/j.drudis.2019.01.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
74 Zhou Y, Li H, Luo L, Chen Y, Chen Q, Bian W, Yang Y, Tang J. Acupoint injection therapy for diabetic retinopathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24119. [PMID: 33429782 DOI: 10.1097/MD.0000000000024119] [Reference Citation Analysis]
75 Jeng C, Hsieh Y, Yang C, Yang C, Lin C, Wang I. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression. Ophthalmology Retina 2018;2:38-45. [DOI: 10.1016/j.oret.2017.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
76 Chung YR, Park SW, Choi SY, Kim SW, Moon KY, Kim JH, Lee K. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy. Cardiovasc Diabetol 2017;16:4. [PMID: 28061854 DOI: 10.1186/s12933-016-0486-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
77 Tan TE, Fenner BJ, Barathi VA, Tun SBB, Wey YS, Tsai ASH, Su X, Lee SY, Cheung CMG, Wong TY, Mehta JS, Teo KYC. Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress. Front Genet 2021;12:795010. [PMID: 34950193 DOI: 10.3389/fgene.2021.795010] [Reference Citation Analysis]
78 Wang J, Lin J, Schlotterer A, Wu L, Fleming T, Busch S, Dietrich N, Hammes H. CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta Diabetol 2014;51:813-21. [DOI: 10.1007/s00592-014-0616-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
79 Gui F, You Z, Fu S, Wu H, Zhang Y. Endothelial Dysfunction in Diabetic Retinopathy. Front Endocrinol (Lausanne) 2020;11:591. [PMID: 33013692 DOI: 10.3389/fendo.2020.00591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
80 Poirier M, Awale M, Roelli MA, Giuffredi GT, Ruddigkeit L, Evensen L, Stooss A, Calarco S, Lorens JB, Charles RP, Reymond JL. Identifying Lysophosphatidic Acid Acyltransferase β (LPAAT-β) as the Target of a Nanomolar Angiogenesis Inhibitor from a Phenotypic Screen Using the Polypharmacology Browser PPB2. ChemMedChem 2019;14:224-36. [PMID: 30520265 DOI: 10.1002/cmdc.201800554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
81 Chen M, Lv H, Gan J, Ren J, Liu J. Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats. Front Physiol 2017;8:1065. [PMID: 29311988 DOI: 10.3389/fphys.2017.01065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
82 Noh M, Zhang H, Kim H, Park S, Kim YM, Kwon YG. Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization. Front Pharmacol 2021;12:695009. [PMID: 34149436 DOI: 10.3389/fphar.2021.695009] [Reference Citation Analysis]
83 Yasir ZH, Hassan AD, Rajiv K. Diabetic retinopathy (DR) among 40 years and older Saudi population with diabetes in Riyadh governorate, Saudi Arabia - A population based survey. Saudi J Ophthalmol 2019;33:363-8. [PMID: 31920446 DOI: 10.1016/j.sjopt.2019.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Semeraro F, Cancarini A, Morescalchi F, Romano MR, dell’Omo R, Ruggeri G, Agnifili L, Costagliola C. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy. Diabetes Metab. 2014;40:445-451. [PMID: 24878492 DOI: 10.1016/j.diabet.2014.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
85 Zhu S, Liu B, Hao M, Fan Y, Qian C, Teng P, Zhou X, Hu L, Liu W, Yuan Z, Li Q. Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy. Inflammation 2017;40:1475-86. [DOI: 10.1007/s10753-017-0571-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
86 Mendonca HR, Carpi-Santos R, da Costa Calaza K, Blanco Martinez AM. Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation. Neural Regen Res. 2020;15:625-635. [PMID: 31638084 DOI: 10.4103/1673-5374.266910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
87 Mirhoseini M, Saleh N, Momeni A, Deris F, Asadi-Samani M. A study on the association of diabetic dermopathy with nephropathy and retinopathy in patients with type 2 diabetes mellitus. J Nephropathol. 2016;5:139-143. [PMID: 27921026 DOI: 10.15171/jnp.2016.26] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
88 Chen Y, Wang W, Liu F, Tang L, Tang R, Li W. 9-cis-retinoic acid improves sensitivity to platelet-derived growth factor-BB via RXRα and SHP-1 in diabetic retinopathy. Biochemical and Biophysical Research Communications 2015;465:810-6. [DOI: 10.1016/j.bbrc.2015.08.093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
89 Wang B, Yu J, Wang T, Shen Y, Lin D, Xu X, Wang Y. Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow. Acta Diabetol 2018;55:419-27. [DOI: 10.1007/s00592-018-1109-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Bayan N, Yazdanpanah N, Rezaei N. Role of Toll-Like Receptor 4 in Diabetic Retinopathy. Pharmacol Res 2021;:105960. [PMID: 34718133 DOI: 10.1016/j.phrs.2021.105960] [Reference Citation Analysis]
91 Al-Moujahed A, Hien DL, Akhavanrezayat A, Pham BH, Tuong Ngoc TT, Doan HL, Yaşar Ç, Lajevardi S, Nguyen HV, Nguyen QD. Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease. Am J Ophthalmol Case Rep 2021;21:101027. [PMID: 33615039 DOI: 10.1016/j.ajoc.2021.101027] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]